Key result
The Thrombostat 4000 using ADP or epinephrine detected more patients with primary hemostasis defects than bleeding times, with coefficients of variance between 9-12%.
Why the study?
Does the Thrombostat 4000 accurately assess primary hemostasis defects compared to bleeding times in normal volunteers and patients?
Observational
Does the Thrombostat 4000 accurately assess primary hemostasis defects compared to bleeding times in normal volunteers and patients?
The Thrombostat 4000 can detect primary hemostasis defects and aspirin effects using epinephrine, but its routine use is limited by inconsistencies in collagen filter coatings.
No takes yet. Share an insight, caveat, or question.
Thrombostat 4000 may improve detection of primary hemostasis defects; leaves open routine adoption pending prospective validation.
Alshameeri et al. (1995) conducted an observational in Primary hemostasis defects. Thrombostat 4000 vs. Bleeding times was evaluated on Detection of primary hemostasis defects. The Thrombostat 4000 using ADP or epinephrine detected more patients with primary hemostasis defects than bleeding times, with coefficients of variance between 9-12%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: